In Q1FY24, the Indian Pharma Market (IPM) experienced a 10.7% YoY sales growth, primarily due to a 16.0% increase in realization, whereas volume declined by 13.9%. The growth from new product launches was approximately 8.6% compared to the same quarter last year. IPM witnessed growth across various therapy areas during Q1FY24.